Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-28 5:30 pm Purchase | 2022-09-19 | 13G | Allakos Inc. ALLK | Logos Global Management LP | 5,936,666 7.000% | 5,936,666 (New Position) | Filing History |
| 2022-05-02 4:02 pm Purchase | 2022-04-20 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,550,000 5.200% | 680,000 (+78.16%) | Filing History |
| 2022-03-31 4:23 pm Purchase | 2022-03-21 | 13D | Design Therapeutics, Inc. DSGN | Logos Global Management LP | 2,812,501 5.000% | 2,812,501 (New Position) | Filing History |
| 2022-03-18 5:04 pm Purchase | 2022-03-08 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 265,000 6.900% | 265,000 (New Position) | Filing History |
| 2022-02-15 08:37 am Sale | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 150,000 4.600% | -33,000 (-18.03%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Logos Global Management LP | 0 0.000% | -114,911 (Position Closed) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing History |
| 2022-02-14 3:16 pm Sale | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 870,000 3.000% | -630,000 (-42.00%) | Filing History |
| 2022-02-14 3:00 pm Sale | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Logos Global Management LP | 145,000 3.000% | -105,000 (-42.00%) | Filing History |
| 2022-02-14 2:47 pm Sale | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Logos Global Management LP | 0 0.000% | -1,495,000 (Position Closed) | Filing History |
| 2022-02-14 2:05 pm Purchase | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Logos Global Management LP | 150,000 0.400% | 150,000 (New Position) | Filing History |
| 2022-02-14 1:36 pm Sale | 2021-12-31 | 13G | Nkarta, Inc. NKTX | Logos Global Management LP | 0 0.000% | -1,927,180 (Position Closed) | Filing History |
| 2022-01-26 4:27 pm Sale | 2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 0 0.000% | -1,339,793 (Position Closed) | Filing History |
| 2021-12-27 5:25 pm Purchase | 2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 183,000 5.600% | 183,000 (New Position) | Filing History |
| 2021-12-02 4:53 pm Purchase | 2021-11-22 | 13G | COMPASS Pathways plc CMPS | Logos Global Management LP | 1,400,000 3.400% | 1,400,000 (New Position) | Filing History |
| 2021-11-15 2:24 pm Purchase | 2021-11-01 | 13G | Atreca, Inc. BCEL | Logos Global Management LP | 996,584 3.300% | 996,584 (New Position) | Filing History |
| 2021-09-29 09:30 am Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Logos Global Management LP | 1,495,000 8.800% | 1,495,000 (New Position) | Filing History |
| 2021-09-13 5:12 pm Unchanged | 2021-09-02 | 13G | Forte Biosciences, Inc. FBRX | Logos Global Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-09-09 12:30 pm Purchase | 2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Logos Global Management LP | 1,339,793 9.400% | 1,339,793 (New Position) | Filing History |
| 2021-08-16 2:37 pm Purchase | 2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 3,894,392 7.600% | 3,894,392 (New Position) | Filing History |